News
The U.S. Food and Drug Administration has extended its review of Bayer's experimental menopause relief drug, the German ...
The agency told Bayer it needs additional time to review the non-hormonal drug, called elinzanetant. Regulators in Canada and ...
Bayer Leverkusen veteran Jonas Hofmann is coming off a tough season with very limited playing time.However, after Erik ten ...
The Federal Cartel Office have extended the deadline it set for Bayer Leverkusen, Wolfsburg, RB Leipzig and Hannover to ...
6don MSN
Gusttavo netted a fifth 10 minutes after the restart, at which point Ten Hag made another wave of changes. On came Edmond ...
Erik ten Hag has insisted Granit Xhaka is “too important” for Bayer Leverkusen to allow to leave despite the midfielder ...
Explore more
Bayer announced an FDA review extension for Elinzanetant, its experimental menopausal hot flash therapy. Approval remains on track. REad more here.
Bayer said the Food and Drug Administration extended the review period for its new drug application of elinzanetant, a treatment for moderate to severe vasomotor symptoms, also known as hot flashes, ...
Bayer is a deep contrarian play, trading at less than 6x P/E, with potential for 100%+ upside if litigation risks subside.
14don MSN
The hot flashes and night sweats that plague breast cancer survivors during years-long hormone-suppressing therapy are eased by an experimental non-hormonal drug being developed by Bayer , according ...
At the sixth edition of e4m Health & Wellness Marketing Awards, Bayer Consumer bagged 10 metals for its outstanding work, creativity and innovation. The brand won 10 metals including 1 gold, 5 silvers ...
There was a ceiling,” he said. "I saw the chance to do something different—something I could shape from scratch.” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results